Literature DB >> 11043647

Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: plasma and saliva analysis.

E T Moolchan1, E J Cone, A Wstadik, M A Huestis, K L Preston.   

Abstract

Several reports suggest a prolonged elimination of cocaine and metabolites after chronic use compared with single or occasional use. This study was designed to measure the half-lives of cocaine in plasma and saliva of individuals who consumed cocaine on a frequent basis. The disposition and elimination patterns of cocaine and metabolites in the body fluids of chronic high-dose cocaine users during acute cessation of use were investigated. Plasma and saliva specimens were collected over a 12-h period during cessation and analyzed by gas chromatography-mass spectrometry. Pharmacokinetic parameters were derived by noncompartmental analysis of plasma and saliva data. Results indicated a cocaine terminal T(1/2) of 3.8 h in plasma and 7.9 h in saliva. The terminal T(1/2) of benzoylecgonine was 6.6 h in plasma and 9.2 h in saliva. Compared with prior studies of acute low-dose cocaine administration, these findings suggest that cocaine's half-life is longer in active street users than in occasional users though the half-life of its main metabolite benzoylecgonine remains similar (as do cocaine saliva-to-plasma ratios). Thus, regular use of cocaine appears to alter the disposition and elimination of cocaine when compared to single or occasional use.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11043647     DOI: 10.1093/jat/24.7.458

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  7 in total

1.  Revisiting a physiologically based pharmacokinetic model for cocaine with a forensic scope.

Authors:  María Elena Bravo-Gómez; Laura Nayeli Camacho-García; Luz Alejandra Castillo-Alanís; Miguel Ángel Mendoza-Meléndez; Alejandra Quijano-Mateos
Journal:  Toxicol Res (Camb)       Date:  2019-03-13       Impact factor: 3.524

2.  Oral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration.

Authors:  Kayla N Ellefsen; Marta Concheiro; Sandrine Pirard; David A Gorelick; Marilyn A Huestis
Journal:  Forensic Sci Int       Date:  2016-01-22       Impact factor: 2.395

3.  Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients.

Authors:  Riet Dams; Robin E Choo; Willy E Lambert; Hendree Jones; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2006-09-27       Impact factor: 4.492

4.  Cocaethylene, simultaneous alcohol and cocaine use, and liver fibrosis in people living with and without HIV.

Authors:  Javier A Tamargo; Kenneth E Sherman; Rafick-Pierre Sékaly; Rebeka Bordi; Daniela Schlatzer; Shenghan Lai; Jag H Khalsa; Raul N Mandler; Richard L Ehman; Marianna K Baum
Journal:  Drug Alcohol Depend       Date:  2022-01-12       Impact factor: 4.852

5.  The Saliva Exposome for Monitoring of Individuals' Health Trajectories.

Authors:  Vincent Bessonneau; Janusz Pawliszyn; Stephen M Rappaport
Journal:  Environ Health Perspect       Date:  2017-07-20       Impact factor: 9.031

6.  Cocaine use associated gut permeability and microbial translocation in people living with HIV in the Miami Adult Study on HIV (MASH) cohort.

Authors:  Jacqueline Hernandez; Javier A Tamargo; Sabrina Sales Martinez; Haley R Martin; Adriana Campa; Rafick-Pierre Sékaly; Rebeka Bordi; Kenneth E Sherman; Susan D Rouster; Heidi L Meeds; Jag H Khalsa; Raul N Mandler; Shenghan Lai; Marianna K Baum
Journal:  PLoS One       Date:  2022-10-10       Impact factor: 3.752

7.  Aminorex, a metabolite of the cocaine adulterant levamisole, exerts amphetamine like actions at monoamine transporters.

Authors:  Tina Hofmaier; Anton Luf; Amir Seddik; Thomas Stockner; Marion Holy; Michael Freissmuth; Gerhard F Ecker; Rainer Schmid; Harald H Sitte; Oliver Kudlacek
Journal:  Neurochem Int       Date:  2013-12-01       Impact factor: 4.297

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.